Otsuka Beijing Research Institute
Otsuka Group is committed to supporting people's lives worldwide through innovative and creative pharmaceuticals, functional beverages, and foods. Guided by the corporate philosophy 'Otsuka-people creating new products for better health worldwide,' the company emphasizes 'Flowing Sweat, Understanding, and Creativity' as core principles, fostering a corporate culture of innovation and creativity to contribute to global health and well-being.
Industries
Nr. of Employees
medium (51-250)
Otsuka Beijing Research Institute
Products
Pharmaceutical R&D pipeline (small molecules, biologics and advanced modalities)
A portfolio of investigational and marketed therapeutic candidates across multiple disease areas, including biologics and cell/gene therapy programs in clinical development.
Functional food and beverage products
Consumer products formulated for hydration, nutrient supplementation and daily health maintenance.
Digital therapeutics and clinical support software
Software‑based therapeutic applications and clinical decision/support systems intended to support treatment and disease management, including digital medicine products that integrate therapeutic delivery with adherence monitoring.
Separation membrane device for biologic purification
A membrane‑based separation device developed for purification steps in antibody and biologic manufacturing processes.
Point-of-care diagnostic kits
Rapid diagnostic assays and reader-based point‑of‑care test kits for infectious disease and other indications.
Cell-preservation and processing reagents for regenerative medicine
Reagents for cell suspension, washing and preservation intended for research and regenerative medicine manufacturing workflows.
Pharmaceutical R&D pipeline (small molecules, biologics and advanced modalities)
A portfolio of investigational and marketed therapeutic candidates across multiple disease areas, including biologics and cell/gene therapy programs in clinical development.
Functional food and beverage products
Consumer products formulated for hydration, nutrient supplementation and daily health maintenance.
Digital therapeutics and clinical support software
Software‑based therapeutic applications and clinical decision/support systems intended to support treatment and disease management, including digital medicine products that integrate therapeutic delivery with adherence monitoring.
Separation membrane device for biologic purification
A membrane‑based separation device developed for purification steps in antibody and biologic manufacturing processes.
Point-of-care diagnostic kits
Rapid diagnostic assays and reader-based point‑of‑care test kits for infectious disease and other indications.
Cell-preservation and processing reagents for regenerative medicine
Reagents for cell suspension, washing and preservation intended for research and regenerative medicine manufacturing workflows.
Services
Contract pharmaceutical logistics
Third‑party logistics and distribution services for pharmaceutical companies, including national supply operations, temperature‑controlled handling and regulated distribution.
Contract sterile manufacturing (infusion products)
Contract manufacturing services for sterile parenteral and infusion products provided via high-capacity sterile production facilities and GMP operations.
Collaborative R&D, licensing and M&A advisory
Licensing, asset acquisition, joint venture formation and collaborative R&D arrangements to support development and commercialization of therapeutics and devices.
Medical device commercialization and distribution services
Support for device product launches, market access and distribution agreements including exclusive distribution arrangements.
BCP-enabled pharmaceutical distribution center operations
Operation of distribution centers designed to support business continuity and stable supply of pharmaceuticals under emergency and contingency scenarios.
Corporate venture and investment for regenerative medicine
Equity investment and strategic support for companies developing iPSC-derived and other regenerative therapeutics to accelerate clinical translation and business development.
Contract pharmaceutical logistics
Third‑party logistics and distribution services for pharmaceutical companies, including national supply operations, temperature‑controlled handling and regulated distribution.
Contract sterile manufacturing (infusion products)
Contract manufacturing services for sterile parenteral and infusion products provided via high-capacity sterile production facilities and GMP operations.
Collaborative R&D, licensing and M&A advisory
Licensing, asset acquisition, joint venture formation and collaborative R&D arrangements to support development and commercialization of therapeutics and devices.
Medical device commercialization and distribution services
Support for device product launches, market access and distribution agreements including exclusive distribution arrangements.
BCP-enabled pharmaceutical distribution center operations
Operation of distribution centers designed to support business continuity and stable supply of pharmaceuticals under emergency and contingency scenarios.
Corporate venture and investment for regenerative medicine
Equity investment and strategic support for companies developing iPSC-derived and other regenerative therapeutics to accelerate clinical translation and business development.
Expertise Areas
- Clinical trial management
- Regulatory compliance and submissions (drugs, biologics and devices)
- Regulatory strategy for expedited device pathways
- Biologics and antibody discovery
Key Technologies
- Monoclonal antibody discovery and development
- Bispecific antibody therapeutics
- Cell therapy and CAR-T manufacturing methods
- Gene therapy development workflows (AAV and others)